Åsa Björndal

2.6k total citations · 2 hit papers
24 papers, 2.2k citations indexed

About

Åsa Björndal is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Åsa Björndal has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 16 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Åsa Björndal's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (7 papers). Åsa Björndal is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (7 papers). Åsa Björndal collaborates with scholars based in Sweden, United States and Italy. Åsa Björndal's co-authors include Dan R. Littman, Éva Mária Fenyõ, Gabriella Scarlatti, Jan Albert, Hongkui Deng, J R Fiore, E M Fenyö, Robert Fredriksson, Marianne Jansson and Jaroslav Albert and has published in prestigious journals such as Nature Medicine, Nature Methods and Journal of Virology.

In The Last Decade

Åsa Björndal

22 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

1997 525 citations Åsa Björndal, Hongkui Deng et al. Journal of Virology profile →
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression

1997 519 citations Gabriella Scarlatti, Eleonora Tresoldi et al. Nature Medicine profile →

Peers

Countries citing papers authored by Åsa Björndal

Since Specialization

Citations

This map shows the geographic impact of Åsa Björndal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Björndal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Björndal more than expected).

Fields of papers citing papers by Åsa Björndal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Björndal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Björndal. The network helps show where Åsa Björndal may publish in the future.

Co-authorship network of co-authors of Åsa Björndal

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Björndal. A scholar is included among the top collaborators of Åsa Björndal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Björndal. Åsa Björndal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Minimum Information about a High Containment Laboratory Experiment (MIHCLE) reporting standard 2025 ·Nature Methods ·Jonathan J. Ewbank, Bernadett Pályi, Åsa Björndal, Romain David, (unknown), Kurt Zatloukal	0
2	Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers 2021 ·Scientific Reports ·Nina Lagerqvist, Kimia T. Maleki, (unknown), (unknown), Joakim Dillner, (unknown), Tor Monsen, Mattias N.E. Forsell, Jenny Eriksson, Gordana Bogdanović, Sandra Muschiol, (unknown), (unknown), (unknown), Shaman Muradrasoli, Mia Brytting, Åsa Björndal, Thomas Åkerlund, Charlotta Nilsson, Jonas Klingström	22
3	Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017 2020 ·Eurosurveillance ·Sandra Appelt, Daniela Jacob, (unknown), Andreas Bråve, Åsa Björndal, Antonino Di, Roland Grunow	5
4	Harmonization of European Laboratory Response Networks by Implementing CWA 15793: Use of a Gap Analysis and an “Insider” Exercise as Tools 2013 ·Biosecurity and Bioterrorism Biodefense Strategy Practice and Science ·B. Sundqvist, (unknown), Henk J. Wisselink, Ben Peeters, Bart J. van Rotterdam, (unknown), Sándor Bereczky, (unknown), Åsa Björndal, Sylvie Zini, (unknown), Rickard Knutsson	8
5	Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate 2006 ·Virology ·Mattias Mild, Åsa Björndal, Patrik Medstrand, Éva Mária Fenyõ	5
6	Coreceptor Usage of Primary HIV Type 1 Isolates Obtained from Different Lymph Node Subsets 2005 ·AIDS Research and Human Retroviruses ·Charlotte Casper, Mattias Mild, Marianne Jansson, Anders Karlsson, (unknown), Göran Bratt, (unknown), Peter Biberfeld, Åsa Björndal, Jan Albert, Mikuláš Popovič, Éva Mária Fenyõ	0
7	CCR5 or CXCR4 Is Required for Efficient Infection of Peripheral Blood Mononuclear Cells by Promiscuous Human Immunodeficiency Virus Type 2 Primary Isolates 2002 ·AIDS Research and Human Retroviruses ·Andreas Mörner, Åsa Björndal, Ann-Charlotte Leandersson, Jan Albert, Ewa Björling, Marianne Jansson	18
8	Impact of antenatal HIV screening to prevent HIV infection in children in Norway 1987–99 2002 ·Journal of Medical Screening ·Preben Aavitsland, Øivind Anti Nilsen, A Lystad, Åsa Björndal	5
9	Length Variation of Glycoprotein 120 V2 Region in Relation to Biological Phenotypes and Coreceptor Usage of Primary HIV Type 1 Isolates 2001 ·AIDS Research and Human Retroviruses ·Marianne Jansson, (unknown), Gabriella Scarlatti, Åsa Björndal, Shunji Matsuda, Paolo Rossi, Jan Albert, Hans Wigzell	31
10	Protection of Neutralization Epitopes in the V3 Loop of Oligomeric Human Immunodeficiency Virus Type 1 Glycoprotein 120 by N-Linked Oligosaccharides in the V1 Region 2001 ·AIDS Research and Human Retroviruses ·(unknown), Anders Bolmstedt, Kristian Schønning, Åsa Björndal, (unknown), Éva Mária Fenyõ, Sigvard Olofsson	42
11	Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS. 2000 ·PubMed ·Marianne Jansson, (unknown), Åsa Björndal, (unknown), Paolo Rossi, (unknown), M Popovic, Jan Albert, Hans Wigzell	39
12	Phenotypic Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Isolates of Ethiopian AIDS Patients 1999 ·AIDS Research and Human Retroviruses ·Åsa Björndal, Anders Sönnerborg, Charlotte Tscherning, Jan Albert, Éva Mária Fenyõ	120
13	Differences in Chemokine Coreceptor Usage between Genetic Subtypes of HIV-1 1998 ·Virology ·Charlotte Tscherning, Annette Alaeus, Robert Fredriksson, Åsa Björndal, Hongkui Deng, Dan R. Littman, Éva Mária Fenyõ, Jan Albert	209
14	Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Isolates in Two Groups of HIV‐1‐Infected Long‐Term Nonprogressors 1997 ·The Journal of Infectious Diseases ·Yijun Zhang, C Fracasso, J R Fiore, Åsa Björndal, Gioacchino Angarano, A. Gringeri, Eva Maria Fenyö	67
15	In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression breakdown → 1997 ·Nature Medicine ·Gabriella Scarlatti, Eleonora Tresoldi, Åsa Björndal, Robert Fredriksson, (unknown), (unknown), Mauro Malnati, Alberto Plebani, Antonio G. Siccardi, Dan R. Littman, Éva Mária Fenyõ, Paolo Lusso	519
16	Biological correlates of HIV-1 heterosexual transmission 1997 ·AIDS ·J R Fiore, Yijun Zhang, Åsa Björndal, Mariantonietta Di Stefano, Gioacchino Angarano, Giuseppe Pastore, Éva Mária Fenyõ	33
17	Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization 1996 ·Journal of Virology ·Jonathan Weber, E M Fenyö, Simon Beddows, Pontiano Kaleebu, Åsa Björndal	94
18	Standard Conditions of Virus Isolation Reveal Biological Variability of HIV Type 1 in Different Regions of the World 1994 ·AIDS Research and Human Retroviruses ·Helga Rübsamen‐Waigmann, Hagen von Briesen, (unknown), Åsa Björndal, Bette Korber, (unknown), Saeed Ranjbar, Peter Tomlinson, Bernardo Galvão‐Castro, Etienne Karita, (unknown), (unknown), (unknown), (unknown), (unknown)	53
19	The Biological Phenotype of HIV-1 Is Usually Retained during and after Sexual Transmission 1994 ·Virology ·J R Fiore, Åsa Björndal, (unknown), Mariantonietta Di Stefano, Gioacchino Angarano, Giuseppe Pastore, Hans Gaines, Éva Mária Fenyõ, Jan Albert	61
20	Cotransfection of HIV-1 Molecular Clones with Restricted Cell Tropism May Yield Progeny Virus with Altered Phenotype 1993 ·AIDS Research and Human Retroviruses ·Wei Tan, Robert Fredriksson, Åsa Björndal, Peter Balfe, Éva Mária Fenyõ	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact